The landscape of dementia analysis has developed significantly with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based exams which can detect Alzheimer's pathology a long time in advance of symptoms emerge. Even though these technological innovations represent exceptional progress in knowing